tiprankstipranks
BeOne Medicines Ltd (HK:6160)
:6160
Hong Kong Market
6160
BeOne Medicines Ltd
RESEARCH TOOLSreports
Want to see HK:6160 full AI Analyst Report?

BeOne Medicines Ltd (6160) Stock News & Sentiment

23 Followers
BeOne Wins First-in-Class U.S. FDA Nod for BCL2 Drug in Relapsed Mantle Cell Lymphoma
Premium
Company Announcements
BeOne Wins First-in-Class U.S. FDA Nod for BCL2 Drug in Relapsed Mantle Cell Lymphoma
10d ago
6160
BeOne Medicines Grants New RSUs to 201 Employees Under Equity Incentive Plan
Premium
Company Announcements
BeOne Medicines Grants New RSUs to 201 Employees Under Equity Incentive Plan
11d ago
6160
BeOne Medicines Files U.S. Shelf Registration to Expand Capital Market Access
Premium
Company Announcements
BeOne Medicines Files U.S. Shelf Registration to Expand Capital Market Access
17d ago
6160
BeOne Medicines Files Form S-3 to Expand U.S. Capital Market Access
Premium
Company Announcements
BeOne Medicines Files Form S-3 to Expand U.S. Capital Market Access
17d ago
6160
BeOne Medicines Issues Q1 2026 Unaudited Results and Cautious Guidance
Premium
Company Announcements
BeOne Medicines Issues Q1 2026 Unaudited Results and Cautious Guidance
18d ago
6160
BeOne Medicines Highlights Global Footprint With Latest Form 10-Q Filing
Premium
Company Announcements
BeOne Medicines Highlights Global Footprint With Latest Form 10-Q Filing
18d ago
6160
BeOne Medicines Posts U.S. Proxy Materials, Highlights Cross-Border Disclosure
Premium
Company Announcements
BeOne Medicines Posts U.S. Proxy Materials, Highlights Cross-Border Disclosure
26d ago
6160
More HK:6160 News >

6160 News on the Web

BeOne Medicines price target raised to $367 from $364 at Leerink
TipRanks News
Bullish
Leerink Partners Keeps Their Buy Rating on BeOne Medicines (ONC)
TipRanks News
Bullish
Citic Securities Sticks to Its Buy Rating for BeOne Medicines Ltd (6160)
TipRanks News
Bullish
BeOne Wins First-in-Class U.S. FDA Nod for BCL2 Drug in Relapsed Mantle Cell Lymphoma
TipRanks News
Bullish
BeOne Medicines’ Beqalzi granted accelerated approval by FDA
TipRanks News
Bullish
BeOne Medicines Grants New RSUs to 201 Employees Under Equity Incentive Plan
TipRanks News
Bullish
BeOne Medicines Ltd (6160) Gets a Buy from CMBC International
TipRanks News
Bullish
UBS Reaffirms Their Buy Rating on BeOne Medicines Ltd (6160)
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
HK:6160
Sector Average
Media Buzz
This Week3 articles
Weekly Average8.5 articles
News Sentiment
This Week100%
Sector Average78%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is HK:6160’s Media Buzz Sentiment?
3 articles about HK:6160 were published this week. In an average week, 8.5 articles are published.
    What is HK:6160’s weekly average amount of articles?
    In an average week, 8.5 articles about HK:6160 are published.
      What is HK:6160’s News Sentiment?
      100% of articles about HK:6160 were positive this week, compared to its sector average of 78%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        ILAIsland Pharmaceuticals Ltd
        TLSATiziana Life Sciences
        Showing the stocks with the most bullish news sentiment over the past week